Syncona Portfolio Ltd
An institutional investment manager in St Peter Port, Guernsey. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 7, 2026. SEC CIK 1725042.
- Reported value$26.6m
- Positions1
Holdings: 1 position
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Autolus Therapeutics plcAUTL | SPON ADS | 05280R100 | 26.6 | 100.0% | 16,640,720 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Century TherapeuticsIPSC | Common Stock | 15673T100 | 0.0 | 0.0% | 0 | Sold out−1,213,056 |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-338587 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.